Correlation Between Cannabis Sativa and Zynerba Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cannabis Sativa and Zynerba Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannabis Sativa and Zynerba Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannabis Sativa and Zynerba Pharmaceuticals, you can compare the effects of market volatilities on Cannabis Sativa and Zynerba Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannabis Sativa with a short position of Zynerba Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannabis Sativa and Zynerba Pharmaceuticals.

Diversification Opportunities for Cannabis Sativa and Zynerba Pharmaceuticals

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between Cannabis and Zynerba is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Cannabis Sativa and Zynerba Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zynerba Pharmaceuticals and Cannabis Sativa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannabis Sativa are associated (or correlated) with Zynerba Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zynerba Pharmaceuticals has no effect on the direction of Cannabis Sativa i.e., Cannabis Sativa and Zynerba Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cannabis Sativa and Zynerba Pharmaceuticals

Given the investment horizon of 90 days Cannabis Sativa is expected to generate 3.18 times more return on investment than Zynerba Pharmaceuticals. However, Cannabis Sativa is 3.18 times more volatile than Zynerba Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Zynerba Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest  5.00  in Cannabis Sativa on August 26, 2024 and sell it today you would lose (3.78) from holding Cannabis Sativa or give up 75.6% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy31.99%
ValuesDaily Returns

Cannabis Sativa  vs.  Zynerba Pharmaceuticals

 Performance 
       Timeline  
Cannabis Sativa 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cannabis Sativa are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental indicators, Cannabis Sativa unveiled solid returns over the last few months and may actually be approaching a breakup point.
Zynerba Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zynerba Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Zynerba Pharmaceuticals is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Cannabis Sativa and Zynerba Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cannabis Sativa and Zynerba Pharmaceuticals

The main advantage of trading using opposite Cannabis Sativa and Zynerba Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannabis Sativa position performs unexpectedly, Zynerba Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zynerba Pharmaceuticals will offset losses from the drop in Zynerba Pharmaceuticals' long position.
The idea behind Cannabis Sativa and Zynerba Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets